Suven Pharmaceuticals' chief strategy officer resigns

Suven Pharmaceuticals announced the resignation of Mr. Subba Raju Komaravolu, Chief Strategy Officer and Senior Management Personnel, effective at the close of working hours on March 31, 2025. The company disclosed the resignation in a filing to the BSE and NSE on March 28, 2025, citing Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Komaravolu's resignation letter, dated January 9, 2025, indicated personal reasons for his departure. Suven Pharmaceuticals assured stakeholders of a smooth transition and acknowledged Mr. Komaravolu's contributions, particularly in the Disha program and strategic initiatives.